Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial.
Mochizuki I, Takiuchi H, Ikejiri K, Nakamoto Y, Kinugasa Y, Takagane A, Endo T, Shinozaki H, Takii Y, Takahashi Y, Mochizuki H, Kotake K, Kameoka S, Takahashi K, Watanabe T, Watanabe M, Boku N, Tomita N, Matsubara Y, Sugihara K.
Mochizuki I, et al. Among authors: takagane a.
Br J Cancer. 2012 Mar 27;106(7):1268-73. doi: 10.1038/bjc.2012.86. Epub 2012 Mar 13.
Br J Cancer. 2012.
PMID: 22415232
Free PMC article.
Clinical Trial.